English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Well-Defined Bifunctional Dendrimer Bearing 54 Nitric Oxide-Releasing Moieties and 54 Ursodeoxycholic Acid Groups Presenting High Anti-Inflammatory Activity

Garzon-Porras, A. M., Bertuzzi, D. L., Lucas, K., & Ornelas, C. (2022). Well-Defined Bifunctional Dendrimer Bearing 54 Nitric Oxide-Releasing Moieties and 54 Ursodeoxycholic Acid Groups Presenting High Anti-Inflammatory Activity. ACS Biomaterials Science & Engineering, 8(12), 5171-5187. doi:10.1021/acsbiomaterials.2c00713.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Garzon-Porras, Ana M.1, Author
Bertuzzi, Diego L.1, Author
Lucas, Kurt2, Author           
Ornelas, Catia1, Author
Affiliations:
1external, ou_persistent22              
2Multiphase Chemistry, Max Planck Institute for Chemistry, Max Planck Society, ou_1826290              

Content

show
hide
Free keywords: -
 Abstract: Nitric oxide (NO) and ursodeoxycholic acid (UDCA) are endogenous molecules involved in physiological processes associated with inflammation. Since inflammatory processes are present in the mechanisms of many diseases, these molecules are important for the development of new drugs. Herein, we describe the synthesis of a well-defined bifunctional dendrimer with 108 termini bearing 54 NO-releasing groups and 54 UDCA units (Dendri-(NO/UDCA)54). For comparison, a lower-generation dendrimer bearing 18 NO-releasing groups and 18 UDCA units (Dendri-(NO/UDCA)18) was also synthesized. The anti-inflammatory activity of these dendrimers was evaluated, showing that the bifunctional dendrimers have an inverse correlation between concentration and anti-inflammatory activity, with an effect dramatically pronounced for Dendri-(NO/UDCA)5420, which at just 0.25 nM inhibited 76.1% of IL-8 secretion. Data suggest that nanomolar concentrations of these dendrimers aid in releasing NO in a safe and controlled way. This bifunctional dendrimer has great potential as a drug against multifactorial diseases associated with inflammatory processes.

Details

show
hide
Language(s): eng - English
 Dates: 2022-11-22
 Publication Status: Published online
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: ACS Biomaterials Science & Engineering
  Abbreviation : acs biomater. sci. eng.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Washington, DC : American Chemical Society
Pages: - Volume / Issue: 8 (12) Sequence Number: - Start / End Page: 5171 - 5187 Identifier: ISSN: 2373-9878
CoNE: https://pure.mpg.de/cone/journals/resource/2373-9878